A Combination of AKR1B10 and CA19-9 Improves the Diagnosis of PDAC

Translational Research on Locally Advanced Pancreatic Adenocarcinoma

NCT03009253 ·Status: UNKNOWN ·Phase: NA

INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors

NCT04436679 ·Status: COMPLETED

Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis

NCT06307080 ·Status: RECRUITING ·Phase: NA

Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients

NCT05947825 ·Status: UNKNOWN ·Phase: PHASE2

A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer

NCT04624217 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC

NCT06750861 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Dose Escalation and Dose Expansion Study of GAS in Subjects With Metastatic Pancreatic Adenocarcinoma

NCT06229496 ·Status: RECRUITING ·Phase: PHASE1

Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer

NCT05201729 ·Status: UNKNOWN

Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic Cancer

NCT02570711 ·Status: TERMINATED ·Phase: PHASE2

SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer

NCT04181645 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of SHR-1020 Combined With Albumin-bound Paclitaxel in the Second-line Treatment of Pancreatic Cancer

NCT04814485 ·Status: UNKNOWN ·Phase: PHASE2

Study on Single-cell Regulons Atlas of Pancreatic Ductal Adenocarcinoma

NCT06720454 ·Status: COMPLETED

Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

NCT02869802 ·Status: RECRUITING

SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer

NCT05185869 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Diffusion MRI for Pancreatic Adenocarcinoma

NCT02896946 ·Status: COMPLETED ·Phase: NA

Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients

NCT06147154 ·Status: COMPLETED

Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

NCT05669482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Tislelizumab With Anlotinib and Chemotherapy for Second-line Treatment of Pancreatic Cancer

NCT05681390 ·Status: UNKNOWN ·Phase: PHASE2

A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy

NCT07235202 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses

NCT04603586 ·Status: COMPLETED ·Phase: NA

Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas

NCT03779464 ·Status: UNKNOWN ·Phase: PHASE2

The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer

NCT03076502 ·Status: UNKNOWN

Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

NCT02101021 ·Status: TERMINATED ·Phase: PHASE3

A Study of Pancreatic Cancer in Xenografts From Liver Metastases

NCT01774643 ·Status: COMPLETED

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

NCT02723331 ·Status: COMPLETED ·Phase: PHASE2